Nancy T. Chang

Nancy T. Chang has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Sciclone Pharmaceuticals Inc, Galera Therapeutics, Inc. and W&T Offshore Inc. Between 26 August 2016 and 3 August 2026, the trades on record add up to 15 filings.

The open-market side counts 1 purchase for €479k alongside 4 sales for €404k. Purchases outweigh sales by €76k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant and 5 option exercises. So far in 2026, the count stands at no purchases and 1 sale.

The record was last updated on 5 August 2026 with a transaction in Galera Therapeutics, Inc. The last purchase on record was published on 2 January 2025, which is 660 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.